Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma

Summary

Multiple Myeloma (MM) is a lethal disease and at present no available treatment method seems to prevent the disease from progressing or relapsing in the long term. NK cells have a relatively high cytotoxic capacity and an anti tumour effect, suggesting a potential as a treatment of MM.This is a phase I, first-in-human, therapeutic exploratory study, where no benefits for the patients can be guaranteed. However, the theoretical implication is that the infused cells may have a positive antitumour effect for the participating individuals.

Timeline

Start

2014-01-01

Primary completion

2021-12-31

Completion

2022-12-31

Drugs

Indications